Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4833536

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Functional
Anti-hypertrophic cardiomyopathy in po dosed Sprague-Dawley rat assessed as reduction in fractional shortening measured upto 24 hrs by echocardiography
4
Total Activities
2
Compounds Tested
2
Activity Types
0
Assay Parameters

Assay Information

Assay Type Functional
Organism Rattus norvegicus
Confidence 1 — Organism
Curated By Autocuration

Target

Rattus norvegicus (CHEMBL376)
Type ORGANISM
Organism Rattus norvegicus

Publication

Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.
Chuang C, Collibee S, Ashcraft L, Wang W, Vander Wal M, Wang X, Hwee DT, Wu Y, Wang J, Chin ER, Cremin P, Zamora J, Hartman J, Schaletzky J, Wehri E, Robertson LA, Malik FI, Morgan BP.
J Med Chem (2021) 64 : 14142 -14152
PubMed 34606259 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 2 6.16 6.22
IC15 2 - -

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4297517 MAVACAMTEN 4.0 2 6.22
CHEMBL4847050 AFICAMTEN 3.0 2 6.10

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4297517 MAVACAMTEN IC50 = 600.0 nM 6.22
CHEMBL4847050 AFICAMTEN IC50 = 800.0 nM 6.10
CHEMBL4847050 AFICAMTEN IC15 = 7.9 uM -
CHEMBL4297517 MAVACAMTEN IC15 = 1.7 uM -